The looming Apple Watch has the wearable health market responding with a flurry of activity.
The Abbott Fresstyle Libre Flash promises to eliminate painful fingersticks and pricks.
UC San Diego chemists demo prototype device that uses lactate in sweat to generate electricity.
A recent study explores how passively collected data can be used to remotely detect low mood and depression.
New Adidas miCoach Fit Smart leaves out core features found in other fitness trackers
The Lark Original and Lark Pro are devices which monitor sleep patterns, gently nudge users awake, and offer personalized advice on how to improve sleep patterns. Lark CEO Julia Lu told TechCrunch the company has sold “tens of thousands” of its devices, with 73 percent of users purportedly experiencing improvement after using Lark Pro for just one month. The company has now officially launched a daytime compliment to their sleep monitor, the Larklife, which shares many features with leading activity monitors like Nike Fuelband.
The West Health Institute has announced the first resident of its newly launched incubator, Sense4Baby, which uses in-house developed technology for remote fetal monitoring.
The West Health Investment Fund has closed two new deals to invest in early stage startups RxAnte and GlySens.
Singularity University graduate students develop MedSensation Tricorder Glove to “quantify touch” and bring self-diagnostics to everyone.
Zamzee has partnered with The President’s Challenge to provide kids and adults with activity monitors and reward healthy behavior.
LUMOback won the Body Slam competition hosted by the USC Body Computing Lab last year and has spent the last eighteen months designing and developing a very cool product with major potential due to the prevalence of back problems, which will effect as much as 80% of the population at some point in their lives.
San Diego-based Sotera Wireless today announced they have raised an additional $12.2M in a Series D round and have signed a strategic partnership with Cerner to distribute their ViSi Mobile system when it receives anticipated FDA approval in Q1 of 2012.